Author

S. Pospisilova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Approach:benchmark study· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1

Frequent Co-Authors

K. Plevova· 2 shared S. Pavlova· 2 shared A. Aufinger· 1 shared A. Culhane· 1 shared A. De Nicolo· 1 shared A. Edsjo· 1 shared A. Flobak· 1 shared A. Patocs· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. Plevova

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 29, 2023

JUN mediates senescence and immune cell recruitment to prevent prostate cancer progression

T. Redmer, M. Raigel, C. Sternberg…·L. Kenner

This study shows JUN suppresses prostate cancer progression by inducing senescence and immune cell recruitment, with JUN depletion accelerating tumor growth.

DOI 10.1101/2023.11.29.569178

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 7, 2023

The Minimal Dataset for Cancer of the 1+Million Genomes Initiative

M. Riba, C. Sala, A. Culhane…·G. Tonon

The paper develops a standardized data model for cancer genomics to enable interoperable data sharing across countries.

DOI 10.1101/2023.10.07.561259

whole-genome sequencingbenchmark study

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 30, 2023

Mobile retroelements induced by hypomethylating agents are restricted to transpose in myeloid malignancies

S. Pavlova, M. Krzyzankova, A. Volakhava…·K. Plevova

The paper investigates whether hypomethylating agents induce retroelement activity and somatic retrotranspositions in myeloid malignancies but finds no de novo retrotransposition events.

DOI 10.1101/2023.07.30.551176

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivMay 29, 2020

Lyn controls chemotaxis and motility of CLL cells via phosphorylation of ROR1.

Z. Dave, O. Vondalova-Blanarova, S. Cada…·V. Bryja

This study shows Lyn phosphorylates ROR1, affecting its surface levels and migratory properties in CLL cells, linking BCR and ROR1 signaling.

DOI 10.3389/fcell.2022.838871

humanproteomics

𝕏 PostBluesky